Cumberland Pharmaceuticals Inc. Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31)
Cumberland Pharmaceuticals Inc. (CPIX) reported Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) of $800.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-11.
Discontinued › Income Statement › Other Income
us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries · last filed 2014-03-11
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2011-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2011-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2011-06-30 was $100.00K.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for fiscal 2013 was $800.00K, a 14.29% increase from fiscal 2012.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for fiscal 2012 was $700.00K, a 600.00% increase from fiscal 2011.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for fiscal 2011 was $100.00K, a 0.00% change from fiscal 2010.
- Cumberland Pharmaceuticals Inc. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for fiscal 2010 was $100.00K.
| Period end | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 3 month | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 6 month | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 9 month | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $800.00K 10-K · filed 2014-03-11 | |||
| 2012-12-31 | $700.00K 10-K · filed 2014-03-11 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $0.00 derived: sum of 2 quarters · filed 2014-03-11 | $100.00K derived: sum of 3 quarters · filed 2014-03-11 | $100.00K 10-K · filed 2014-03-11 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-02 | $100.00K derived: sum of 2 quarters · filed 2012-11-02 | $100.00K 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $100.00K 10-Q · filed 2012-08-09 | $100.00K 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $100.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |